[K2] Understanding the 340B Program: Policy, Patients, and Practical Implications for Managed Care Professionals
Pricing: Free for Members and $30 for Non-Members
Course Description
The 340B drug discount program was created in 1992 to help vulnerable and uninsured patients access prescription medicines at safety net facilities. What was once a small and obscure program now includes $100 billion of drug sales, over 50,000 participating sites of care, and over 33,000 contract pharmacies. It is also the subject of lawsuits and policy debates in Washington, D.C. and in states nationwide, with experts from hospitals, pharmacies, and pharmaceutical manufacturers arguing about what the statute originally intended and should allow today. What is the 340B program, why is it so controversial, and what do managed care pharmacists need to know? Faculty will share their research and experience as they answer these and other questions!
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Explain the history and current state of the 340B program.
- Examine the different perspectives of 340B stakeholders.
- Describe the current and potential implications of the 340B program for managed care pharmacists.
Faculty
Dave Lacknauth, PharmD, MBA, MS, FACHE
Executive Director of Pharmacy Services
Broward Health
Rory Martin, PhD
Senior Principal
IQVIA
Donald E. Nichols, PhD
Principal, Health Policy and Systems Research
Genentech, Inc.
John M. O'Brien, PharmD, MPH
President & CEO
National Pharmaceutical Council
Moderator
Christina Barrington, PharmD
Vice President, Chief Pharmacy Officer
Priority Health
Financial Relationship Disclosures
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Dave Lacknauth, PharmD, MBA, MS, FACHE Faculty | Disclosed no relevant financial relationships. |
Rory Martin, PhD Faculty | Disclosed no relevant financial relationships. |
Donald E. Nichols, PhD Faculty | Employee: Genentech |
John O’Brien, PharmD, MPH Faculty | Disclosed no relevant financial relationships. |
Kristen Tripicchio, PharmD Reviewer | Employee: CarelonRx |
Brittany V. Henry, PharmD, MBA Planner | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
ACPE UAN: 0233-0000-23-066-H04-P
Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: November 15, 2023 • Expiration Date: December 31, 2024
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2023. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.25 Certificate of Completion
Price
Required Hardware/software
Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities